Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Therapeutic guidelines in vasculitis

R Stadler¹, Z Ruszczak

¹Department of Dermatology, Minden's Medical Center, University of Münster, Germany.

International Angiology : a Journal of the International Union of Angiology

|June 1, 1995

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

Experimental dermatology·2024

Same author

Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Adenoma Detection Rate on Colonoscopy: an Argument for Focused Screening?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2022

Same author

Learning from itch - epidermolysis bullosa is a genetically determined barrier disruption and a chronic inflammatory disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

[Calprotectin-a key for diagnosing chronic inflammatory bowel disease in inflammatory dermatoses? : Three case reports].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021

Same author

Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Same journal

Lower intraluminal thrombus load in patients with abdominal aortic aneurysms and blood type O.

International angiology : a journal of the International Union of Angiology·2026

Same journal

Automated three-dimensional ultrasound surveillance after endovascular aortic repair.

International angiology : a journal of the International Union of Angiology·2026

Same journal

Dose-dependent effects of rosuvastatin in deep vein thrombosis: a retrospective cohort study.

International angiology : a journal of the International Union of Angiology·2026

Same journal

Medical treatment versus endarterectomy for symptomatic carotid stenosis: systematic review and meta-analysis. Do we need an updated randomized trial to compare carotid intervention to best medical therapy in patients with symptomatic carotid disease?

International angiology : a journal of the International Union of Angiology·2026

Same journal

Pharmacological thromboprophylaxis after varicose vein thermal ablation in Spain: a national survey.

International angiology : a journal of the International Union of Angiology·2026

Same journal

Effects of information platform-based nursing management on patients with venous thromboembolism: a systematic review and meta-analysis.

International angiology : a journal of the International Union of Angiology·2026

See all related articles

Distinguishing primary cutaneous vasculitis from secondary causes requires thorough diagnosis. Current treatments focus on symptom management with anti-inflammatory and immunosuppressive therapies rather than cures.

Area of Science:

Dermatology
Rheumatology
Immunology

Background:

Cutaneous vasculitis diagnosis is critical to differentiate primary disease from secondary systemic processes.
Accurate patient classification guides appropriate therapeutic strategies for cutaneous vasculitis.
Current treatment approaches for cutaneous vasculitis are predominantly symptomatic and anti-inflammatory.

Purpose of the Study:

To review current therapeutic protocols for managing cutaneous vasculitis.
To highlight the importance of distinguishing primary vasculitis from secondary systemic disease.
To discuss the role of anti-inflammatory and immunosuppressive therapies in disease control.

Main Methods:

Review of existing literature on cutaneous vasculitis treatment.

Related Experiment Videos

Analysis of diagnostic criteria for primary versus secondary vasculitis.

Synthesis of current anti-inflammatory and immunosuppressive therapy protocols.

Main Results:

Clinical differentiation between primary and secondary vasculitis is essential for effective management.
Causative treatments for cutaneous vasculitis are limited.
Symptomatic anti-inflammatory and immunosuppressive therapies are the mainstay for disease control.

Conclusions:

Thorough diagnosis is paramount in managing cutaneous vasculitis.
Current therapeutic strategies focus on symptom control rather than etiological treatment.
This review summarizes established and emerging therapy protocols for cutaneous vasculitis.